INTRAPLEURAL IMMUNOTHERAPY FOR METASTATIC PLEURISIES IN PATIENTS WITH BREAST CANCER
https://doi.org/10.17650/1994-4098-2009-0-3-4-34-38
Abstract
Intrapleural immunotherapy for metastatic pleurisies demonstrates a high efficiency in the treatment of patients with breast cancer (BC). This immunotherapy modality is regarded as one of the stages of complex treatment in patients with disseminated BC and allows its capabilities to be extended for their further management.
About the Authors
K. S. Titov
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
L. V. Demidov
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
M. V. Kiselevsky
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
I. N. Mikhailova
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
I. Zh. Shubina
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
A. N. Gritsai
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
I. E. Sinelnikov
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
L. M. Rodionova
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
References
1. Давыдов М.И., Оразгельдыев К.Р., Волков С.М, Киселевский М.В. Адоптивная иммунотерапия опухолевых плевритов. Здравоохр Туркмен 2000;(3):4—7.
2. Давыдов М.И., Оразгельдыев К.Р., Волков С.М, Киселевский М.В. Адоптивная иммунотерапия опухолевых плевритов. В сб.: Новое в онкологии. Вып. 5. М., 2001. с. 72—88.
3. Кашикова Х.Ш. Лекарственная терапия опухолевых плевритов. Дис. ... канд. мед. наук. М., 1989.
4. Belani C.P., Einardson T.R., Arikian S.R. et al. Cost effectiveness analysis of pleurodesis in the management of malignant pleural effusion. J Oncol Manag 1995;1(2):24.
5. Wallach H.W. Intrapleural tetracycline for malignant pleural effusions. Chest 1975;68:510—2.
6. Hausher F.H., Yarbo J.W. Diagnosis and treatment of malignant pleural effu- sion. Cancer Met Rev 1987;6(1):24—30.
7. Kefford R.F., Woods R.L., Fox R. et al. Intracavitary adriamycin, nitrogen mus- tard and tetracycline in the control of malignant effusions. Med J Austral 1980;2:447—8.
8. Bayly T.C., Kisher D.L., Sybert A. et al. Tetracycline and quinacrine in the con- trol of malignant pleural effusions. Cancer 1978;41:1188—92.
9. Leff A., Hopewell P.C., Costello J. Pleural effusion from malignancy. Ann Int Med 1978;88:532—7.
10. Киселевский М.В. Адоптивная иммунотерапия при злокачественных опухолях. Вестн РАМН 2003;(1):40—4.
11. Чикилева И.О., Халтурина Е.О., Киселевский М.В. Современные подходы и направления в иммунотерапии и иммунопрофилактике злокачест- венных новообразований. Мол мед 2003;(2):40—50.
Review
For citations:
Titov K.S., Demidov L.V., Kiselevsky M.V., Mikhailova I.N., Shubina I.Zh., Gritsai A.N., Sinelnikov I.E., Rodionova L.M. INTRAPLEURAL IMMUNOTHERAPY FOR METASTATIC PLEURISIES IN PATIENTS WITH BREAST CANCER. Tumors of female reproductive system. 2009;(3-4):34-38. (In Russ.) https://doi.org/10.17650/1994-4098-2009-0-3-4-34-38
Views:
598
Email this article 